2-201237962-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000264275.9(CASP8):c.-27+3850A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 152,052 control chromosomes in the GnomAD database, including 13,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 13381 hom., cov: 32)
Consequence
CASP8
ENST00000264275.9 intron
ENST00000264275.9 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.422
Publications
20 publications found
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP8 | NM_001228.5 | c.-27+3850A>G | intron_variant | Intron 2 of 9 | NP_001219.2 | |||
CASP8 | NM_001400648.1 | c.-27+3850A>G | intron_variant | Intron 2 of 9 | NP_001387577.1 | |||
CASP8 | NM_001400651.1 | c.-27+3850A>G | intron_variant | Intron 2 of 9 | NP_001387580.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP8 | ENST00000264275.9 | c.-27+3850A>G | intron_variant | Intron 2 of 9 | 1 | ENSP00000264275.5 | ||||
CASP8 | ENST00000392258.7 | c.-27+3850A>G | intron_variant | Intron 2 of 7 | 1 | ENSP00000376087.3 | ||||
CASP8 | ENST00000471383.5 | n.250+3850A>G | intron_variant | Intron 2 of 4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.411 AC: 62508AN: 151936Hom.: 13382 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
62508
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.411 AC: 62511AN: 152052Hom.: 13381 Cov.: 32 AF XY: 0.404 AC XY: 30056AN XY: 74322 show subpopulations
GnomAD4 genome
AF:
AC:
62511
AN:
152052
Hom.:
Cov.:
32
AF XY:
AC XY:
30056
AN XY:
74322
show subpopulations
African (AFR)
AF:
AC:
13819
AN:
41468
American (AMR)
AF:
AC:
5861
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1347
AN:
3470
East Asian (EAS)
AF:
AC:
1185
AN:
5180
South Asian (SAS)
AF:
AC:
1167
AN:
4828
European-Finnish (FIN)
AF:
AC:
4910
AN:
10548
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32845
AN:
67976
Other (OTH)
AF:
AC:
905
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1892
3784
5675
7567
9459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
781
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.